2025年第18届国际异种移植协会大会(IXA)

◆ 会议时间：2025年9月30日-10月3日
◆ 会议地点：瑞士 日内瓦

◆ 会议简介：

2025年第18届国际异种移植协会(IXA)大会将于2025年9月30日-10月3日在瑞士日内瓦举行，会议由国际异种移植协会(IXA)主办，每两年举行一届。大会计划将重点介绍当前异种移植研究的突破性进展及其在临床应用方面的发展。具体会议将从不同的角度讨论异种移植的监管和伦理问题。此外，还将讨论治疗慢性器官衰竭的补充方法，如干细胞疗法和机械辅助装置，以及它们在特定患者群体中的潜在应用。

国际异种移植协会(IXA)隶属于国际器官移植协会(TTS)，于1998年在蒙特利尔召开的移植学会大会上成立，旨在为那些对异种移植有特殊兴趣的人士提供一个交流的平台。国际器官移植协会(TTS)是成立于1966年，是一个致力于在世界范围内推进器官移植的国际非政府组织。TTS现在全球105个国家拥有超过6700名成员。TTS的使命是在人类移植实践中发挥全球领导力，制定临床实践指导方针，提供先进的教育计划，提高临床护理和科学研究的道德标准水平。TTS每两年组织一次世界大会，与会者超过5000人。

18th Congress of the International Xenotransplantation Association (IXA 2025)

Date: eptember 30 – October 3, 2025
Venue: Geneva, Switzerland

摘要征文投稿：

Call for Abstract Highlights

• May 1, 2025 Submission deadline.
• June 16, 2025 Notification of acceptance.
• June 30, 2025 Presenters must be registered and paid by this date; otherwise the abstract will be removed from the program.
• Rule of two One presenter can present maximum two abstracts during the Congress. Co-authors must be assigned as presenter if more than two abstracts were accepted.
• Resubmission policy Abstracts that have also been submitted to WTC 2025, TTS 2024 or other congresses in the past year are welcome.

点击此处提交您的摘要>>>CLICK HERE TO SUMBIT YOUR ABSTRACT>>>

Abstract Topics for IXA 2025
Cell and Tissue Xenotransplantation (non-islets)

Coagulation and Thrombosis

Ethics, Cultural and Religious Aspects of Xenotransplantation

Genetic Engineering of the Xeno Donor

Immunosuppression and Tolerance

Infectious Risk and Xenozoonoses

Innate Immunity and Inflammation

Islet Xenotransplantation – Clinical and Preclinical Models

Islet Xenotransplantation – Small Animal and In Vitro Models

Methodology / Techniques / Resources

Molecular and Physiologic Incompatibilities

Organ Xenotransplantation – Preclinical Models

Organ Xenotransplantation – Subclinical Models

Organ Xenotransplantation – Clinical Application
Organ Xenotransplantation – Small Animal and In Vitro Models
Regulation and Public Perception of Xenotransplantation

Tissue Engineering and Regenerative Technology

Xeno Pathology and Molecular Mechanisms

Xenoantigens and Antibodies
Other

Abstract Structure

All abstracts should be formatted into the following four sections:

• Introduction: clarifies the motivation for the research presented.
• Methods: provides sufficient detail for others to reproduce what is studied in the research project.
• Results: presents and discusses the results.
• Conclusion: presents the outcome of the work by interpreting the findings and by relating these findings to the motivation stated in the Introduction. Explain the significance of your findings / outcomes and future implications of the results.

Abstract Guidelines

All abstracts must be submitted electronically through the Congress abstract submission website.

• Abstracts will be accepted in English only.
• There is no fee for submitting an abstract.
• There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present two abstracts as oral presentations during the entire Congress. If you have more than 2 abstracts accepted, you will be obliged to identify alternate presenters for any abstract above the first two. The same applies for poster presentations.
• The abstract text body is limited to 3,000 characters (Approx. 400 words) including spaces. A maximum of two figures/images (in JPG, GIF, or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure.
• Tables: do not insert tables into the body of the abstracts, the system will not recognize the format of the table. Tables will need to be uploaded as image files into the body of the abstract.
• Abstracts accepted for presentation will be published electronically in Xenotransplantation, the official journal of the International Xenotransplantation Association. Abstracts not accepted for presentation, or if the presenter is not officially registered to the Congress by June 30, 2025 will not be published. Abstracts will also be posted prior to the Congress in the detailed program section of the Congress website.
• Employees of Commercial Interests: IXA recognizes that employees/spouses of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. Employees of commercial interests should submit abstracts when the content is limited to basic science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products of their employer.
• Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after May 15, 2025. Once an abstract has been scored by reviewers, no change in the body of the abstract will be accepted.
• Presenters of accepted abstracts must confirm their acceptance, register and pay for the Congress by June 30 (early bird deadline), otherwise the abstract will not be published.

Dear colleagues,

We are delighted to invite you to participate in the 18th Congress of the International Xenotransplantation Association, taking place in the cosmopolitan city of Geneva, Switzerland, from September 30 to October 3, 2025. This prestigious event is expected to attract several hundred participants, including leading experts, researchers, and clinicians from around the world who are at the forefront of xenotransplantation science.

After decades of intense pre-clinical research, several clinical organ xenotransplants have been performed in the USA and China over the last two years, indicating that this approach has reached the level of clinical testing. Continuous improvements will be necessary to allow broader applications. 

Geneva, known for its rich history and stunning landscapes, provides the perfect backdrop for a congress dedicated to groundbreaking research and innovative clinical trials in xenotransplantation. Attendees will have the unique opportunity to engage with renowned professionals and gain insights into the latest advancements and future directions of the field.

We are committed to creating an enriching and impactful experience for all participants. Join us in Geneva for an inspiring and memorable event that will shape the future of xenotransplantation.

We look forward to welcoming you and working together to advance the field.

Warm regards,

Muhammad Mansoor Mohiuddin 
IXA President

Léo Bühler 
IXA 2025 Congress Chair